{"id":"https://openalex.org/W1998093226","doi":"https://doi.org/10.1080/02791072.2006.10399846","title":"Comparing Treatments of Alcoholism on Craving and Biochemical Measures of Alcohol Consumptions","display_name":"Comparing Treatments of Alcoholism on Craving and Biochemical Measures of Alcohol Consumptions","alternate_titles":[],"publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W1998093226","doi":"https://doi.org/10.1080/02791072.2006.10399846","mag":"1998093226","pmid":"https://pubmed.ncbi.nlm.nih.gov/17165363"},"language":"en","primary_location":{"id":"doi:10.1080/02791072.2006.10399846","doi":"https://doi.org/10.1080/02791072.2006.10399846","is_oa":false,"landing_page_url":"https://doi.org/10.1080/02791072.2006.10399846","pdf_url":null,"source":{"id":"https://openalex.org/S149515109","display_name":"Journal of Psychoactive Drugs","issn_l":"0279-1072","issn":["0279-1072","2159-9777"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychoactive Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1998093226"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014822508","display_name":"Felice Alfonso Nava","orcid":"https://orcid.org/0000-0002-3103-0355","observed_orcids":["https://orcid.org/0000-0002-3103-0355"]},"institutions":[{"id":"https://openalex.org/I4210135489","display_name":"Ospedale Castelfranco Veneto","ror":"https://ror.org/03yv7qm57","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135489"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Felice Nava","raw_affiliation_strings":["a  Italian Society of Addiction Medicine (FederSerD) , Milano,  Italy","Department of Addiction Medicine, Drug Abuse Unit (Ser.T.), Hospital of Castelfranco Veneto, Via Ospedale, 18, 31033 Castelfranco Veneto-Treviso, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a  Italian Society of Addiction Medicine (FederSerD) , Milano,  Italy","institution_ids":[]},{"raw_affiliation_string":"Department of Addiction Medicine, Drug Abuse Unit (Ser.T.), Hospital of Castelfranco Veneto, Via Ospedale, 18, 31033 Castelfranco Veneto-Treviso, Italy","institution_ids":["https://openalex.org/I4210135489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086646955","display_name":"Stefania Premi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefania Premi","raw_affiliation_strings":["b   Department of Addiction Medicine , Drug and Alcohol Abuse Unit of Brescia ,  Italy","Department of Addiction Medicine , Drug and Alcohol Abuse Unit of Brescia , Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b   Department of Addiction Medicine , Drug and Alcohol Abuse Unit of Brescia ,  Italy","institution_ids":[]},{"raw_affiliation_string":"Department of Addiction Medicine , Drug and Alcohol Abuse Unit of Brescia , Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019217112","display_name":"Ezio Manzato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ezio Manzato","raw_affiliation_strings":["c   Department of Addiction Medicine , Drug and Alcohol Abuse of Legnago-Verona ,  Italy","Department of Addiction Medicine , Drug and Alcohol Abuse of Legnago-Verona , Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c   Department of Addiction Medicine , Drug and Alcohol Abuse of Legnago-Verona ,  Italy","institution_ids":[]},{"raw_affiliation_string":"Department of Addiction Medicine , Drug and Alcohol Abuse of Legnago-Verona , Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103930874","display_name":"Alfio Lucchini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfio Lucchini","raw_affiliation_strings":["d   Department of Addiction Medicine , Drug and Alcohol Abuse of Milano 2 ,  Italy","Department of Addiction Medicine , Drug and Alcohol Abuse of Milano 2 , Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"d   Department of Addiction Medicine , Drug and Alcohol Abuse of Milano 2 ,  Italy","institution_ids":[]},{"raw_affiliation_string":"Department of Addiction Medicine , Drug and Alcohol Abuse of Milano 2 , Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3342,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.79303691,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"38","issue":"3","first_page":"211","last_page":"217"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11207","display_name":"Alcohol Consumption and Health Effects","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.9300000071525574},{"id":"https://openalex.org/keywords/alcohol-craving","display_name":"alcohol craving","score":0.9459999799728394},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/disulfiram","display_name":"disulfiram","score":1.0},{"id":"https://openalex.org/keywords/alcohol-abstinence","display_name":"alcohol abstinence","score":0.5490000247955322},{"id":"https://openalex.org/keywords/ethanol-intake","display_name":"ethanol consumption","score":0.8539999723434448},{"id":"https://openalex.org/keywords/treatment-comparison","display_name":"treatment comparison","score":0.39500001072883606},{"id":"https://openalex.org/keywords/cytoprotection","display_name":"cytoprotection","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2779541405","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Craving","level":3,"score":0.9274179339408875},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.8941938281059265},{"id":"https://openalex.org/C2778523461","wikidata":"https://www.wikidata.org/wiki/Q409665","display_name":"Disulfiram","level":2,"score":0.8478165864944458},{"id":"https://openalex.org/C2780687700","wikidata":"https://www.wikidata.org/wiki/Q210978","display_name":"Abstinence","level":2,"score":0.7777326107025146},{"id":"https://openalex.org/C2781066024","wikidata":"https://www.wikidata.org/wiki/Q156","display_name":"Alcohol","level":2,"score":0.7171881198883057},{"id":"https://openalex.org/C2780161600","wikidata":"https://www.wikidata.org/wiki/Q153","display_name":"Ethanol","level":2,"score":0.5663265585899353},{"id":"https://openalex.org/C2779992327","wikidata":"https://www.wikidata.org/wiki/Q337668","display_name":"Acamprosate","level":5,"score":0.5598461627960205},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5180266499519348},{"id":"https://openalex.org/C2779436514","wikidata":"https://www.wikidata.org/wiki/Q4713263","display_name":"Alcohol dependence","level":3,"score":0.49463483691215515},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4718572795391083},{"id":"https://openalex.org/C3018430727","wikidata":"https://www.wikidata.org/wiki/Q11058472","display_name":"Alcohol intake","level":3,"score":0.4440545439720154},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.35557669401168823},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2977139353752136},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.29757797718048096},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2682722210884094},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.14068293571472168},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1090993583202362},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000427","descriptor_name":"Alcohol Deterrents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000427","descriptor_name":"Alcohol Deterrents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000428","descriptor_name":"Alcohol Drinking","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000428","descriptor_name":"Alcohol Drinking","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D004221","descriptor_name":"Disulfiram","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004221","descriptor_name":"Disulfiram","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012978","descriptor_name":"Sodium Oxybate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012978","descriptor_name":"Sodium Oxybate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013695","descriptor_name":"Temperance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/02791072.2006.10399846","doi":"https://doi.org/10.1080/02791072.2006.10399846","is_oa":false,"landing_page_url":"https://doi.org/10.1080/02791072.2006.10399846","pdf_url":null,"source":{"id":"https://openalex.org/S149515109","display_name":"Journal of Psychoactive Drugs","issn_l":"0279-1072","issn":["0279-1072","2159-9777"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychoactive Drugs","raw_type":"journal-article"},{"id":"pmid:17165363","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17165363","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychoactive drugs","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W32923551","https://openalex.org/W189798547","https://openalex.org/W1966406869","https://openalex.org/W1972579292","https://openalex.org/W1972840128","https://openalex.org/W1978274508","https://openalex.org/W1982198428","https://openalex.org/W1982358260","https://openalex.org/W1983680670","https://openalex.org/W1988613128","https://openalex.org/W1990118494","https://openalex.org/W1990999165","https://openalex.org/W1997585586","https://openalex.org/W2015074898","https://openalex.org/W2019574836","https://openalex.org/W2020778772","https://openalex.org/W2025741619","https://openalex.org/W2040302584","https://openalex.org/W2046894993","https://openalex.org/W2063680446","https://openalex.org/W2076870635","https://openalex.org/W2080429981","https://openalex.org/W2082769267","https://openalex.org/W2083399000","https://openalex.org/W2083412018","https://openalex.org/W2089686306","https://openalex.org/W2093559862","https://openalex.org/W2095520137","https://openalex.org/W2097437544","https://openalex.org/W2098784455","https://openalex.org/W2135792508","https://openalex.org/W2144175661","https://openalex.org/W2149129350","https://openalex.org/W2149790615","https://openalex.org/W2152069265","https://openalex.org/W2158454106","https://openalex.org/W2164441617","https://openalex.org/W2214185525","https://openalex.org/W2396836538","https://openalex.org/W4234198744"],"related_works":["https://openalex.org/W2030206314","https://openalex.org/W2606180404","https://openalex.org/W2066260826","https://openalex.org/W2164937642","https://openalex.org/W2013833800","https://openalex.org/W97934630","https://openalex.org/W2011845889","https://openalex.org/W1983598011"],"abstract_inverted_index":{"An":[0],"open":[1],"randomized":[2],"study":[3,105],"was":[4],"conducted":[5],"to":[6,34,37,80],"compare":[7],"different":[8],"treatments":[9,61,77],"of":[10,20,30,42,89,102],"alcoholism":[11],"on":[12,17],"ethanol":[13],"intake,":[14],"craving,":[15],"and":[16,69,84,114],"biochemical":[18],"measures":[19],"alcohol":[21,67,90],"consumptions.":[22],"Eighty-six":[23],"alcoholics":[24],"were":[25,62,78,95],"abstinent":[26],"for":[27,57],"a":[28],"mean":[29],"two":[31],"weeks":[32],"prior":[33],"random":[35],"assignment":[36],"g-hydroxybutyrate":[38],"(GHB,":[39],"50":[40,48],"mg/kg":[41],"body":[43],"weight":[44],"t.i.d),":[45],"naltrexone":[46],"(NTX,":[47],"mg/day)":[49],"or":[50],"disulfiram":[51],"(DSF,":[52],"200":[53],"mg/":[54],"day)":[55],"treatment":[56],"12":[58],"months.":[59],"All":[60],"equally":[63],"effective":[64],"in":[65,70,97],"reducing":[66],"intake":[68],"maintaining":[71],"abstinence.":[72],"In":[73],"all":[74],"patients,":[75],"the":[76,85,103],"able":[79],"reduce":[81],"both":[82,111],"craving":[83],"altered":[86],"biological":[87],"markers":[88],"abuse.":[91],"The":[92,100],"maximum":[93],"effects":[94],"observed":[96],"GHB-treated":[98],"patients.":[99],"results":[101],"present":[104],"suggest":[106],"that":[107],"GHB":[108],"might":[109],"act":[110],"as":[112],"anticraving":[113],"cellular":[115],"protector":[116],"agent.":[117]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1998093226","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
